Common Mistakes to Avoid The first mistake is treating a 10 mg blend as 10 mg of each compound without checking the label
These effects are dose-dependent and require systemic exposure to the medication
Here are questions that can guide your conversation with the evaluating clinician: About the Medication: "Is a compounded formulation appropriate for my situation, or would you recommend I pursue an FDA-approved branded product through traditional channels?" "Which specific form of semaglutide or tirzepatide is being used (base vs salt form), and how does that affect dosing?" "What is the source of the active pharmaceutical ingredient, and what quality assurance measures are in place?" "How does the compounded version differ from FDA-approved Ozempic, Wegovy, Mounjaro, or Zepbound?" About the Process: "What is the titration schedule you typically recommend, and how long does it take to reach a maintenance dose?" "What happens if I miss a dose or need to delay my injection?" "How long should I expect to stay on this medication to see meaningful results, and what happens if I stop?" "What follow-up monitoring will we do, and how often should I check in with you or another provider?" About Safety: "Given my current medications [list them], are there any interaction concerns?" "What side effects should I watch for that would require urgent medical attention?" "Are there any foods, supplements, or activities I should avoid while taking this medication?" "What should I do if I become pregnant while taking this medication?" About the Pharmacy: "Which pharmacy will be dispensing my medication, and what is their licensing and accreditation status?" "Is this pharmacy licensed in my state?" "What accreditations do you hold (if any), such as PCAB (Pharmacy Compounding Accreditation Board) or similar organizations?" "What quality control measures does the compounding pharmacy use?" "What should I do if I have concerns about the medication I receive?" About Cost and Logistics: "Is there any way to determine whether my insurance might cover traditional GLP-1 medications before I commit to paying out-of-pocket?" "What is the refund or cancellation policy if I experience side effects and need to stop?" "How does billing work-am I charged upfront, after provider approval, or after medication ships?" These questions aren't meant to be confrontational-they're tools for making informed healthcare decisions
Always confirm your math before drawing: if the numbers seem off by a factor of 10 or 1,000, you likely mixed up units
In studies with rodents, these medications caused thyroid tumors, including a type of thyroid cancer called medullary thyroid carcinoma (MTC)
Semaglutide GLP-1 begins to show appetite-suppressing effects soon after starting treatment, with many patients noticing a reduction in hunger within the first week
